Teppei Morikawa
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Cancer Cells and Metastasis
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 74
- Colorectal Cancer Treatments and Studies 20
- Colorectal Cancer Surgical Treatments 18
- Colorectal Cancer Screening and Detection 14
- Cancer Immunotherapy and Biomarkers 8
-
- Renal cell carcinoma treatment 14
- Prostate Cancer Diagnosis and Treatment 10
- Co-authors
- Shuji Ogino (35 shared papers)Charles S. Fuchs (33 shared papers)Zhi Rong Qian (22 shared papers)Mai Yamauchi (26 shared papers)Aya Kuchiba (23 shared papers)Yu Imamura (20 shared papers)Xiaoyun Liao (19 shared papers)Reiko Nishihara (21 shared papers)
- Journals
- Pathology International (9 papers)Clinical Cancer Research (6 papers)PLoS ONE (6 papers)Annals of Surgical Oncology (6 papers)Cancer Science (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Teppei Morikawa
218 papers receiving 12.4k citations
Teppei Morikawa's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 5.2k
- Cancer Research 1.1k
- Pathology and Forensic Medicine 1.2k
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 2.7k
Countries citing papers authored by Teppei Morikawa
This map shows the geographic impact of Teppei Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teppei Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teppei Morikawa more than expected).
Fields of papers citing papers by Teppei Morikawa
This network shows the impact of papers produced by Teppei Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teppei Morikawa. The network helps show where Teppei Morikawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Teppei Morikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion Hit paper breakdown → | 2012 | 1523 |
| 2 | Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Hit paper breakdown → | 2013 | 1248 |
| 3 | Integrated molecular analysis of clear-cell renal cell carcinoma Hit paper breakdown → | 2013 | 1012 |
| 4 | Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival Hit paper breakdown → | 2012 | 713 |
| 5 | Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum Hit paper breakdown → | 2012 | 512 |
| 6 | 2012 | 470 | |
| 7 | Genetic Mechanisms of Immune Evasion in Colorectal Cancer Hit paper breakdown → | 2018 | 411 |
| 8 | Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication Hit paper breakdown → | 2013 | 366 |
| 9 | 2009 | 310 | |
| 10 | 2012 | 226 | |
| 11 | 2012 | 225 | |
| 12 | 2012 | 223 | |
| 13 | 2011 | 181 | |
| 14 | 2014 | 171 | |
| 15 | 2011 | 155 | |
| 16 | 2013 | 148 | |
| 17 | 2015 | 136 | |
| 18 | 2015 | 134 | |
| 19 | Molecular classification and diagnostics of upper urinary tract urothelial carcinoma Hit paper breakdown → | 2021 | 123 |
| 20 | 2007 | 121 |
About Teppei Morikawa
Teppei Morikawa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Surgery and Cancer Research, having authored 234 papers that have together received 12.6k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (26 papers), Bladder and Urothelial Cancer Treatments (21 papers), Colorectal Cancer Treatments and Studies (20 papers), Colorectal Cancer Surgical Treatments (18 papers), Colorectal Cancer Screening and Detection (14 papers), Renal cell carcinoma treatment (14 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (1.1k citations), Pathology and Forensic Medicine (1.2k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Molecular Biology (2.7k citations). Teppei Morikawa has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shuji Ogino, Charles S. Fuchs, Zhi Rong Qian, Mai Yamauchi, Aya Kuchiba, Yu Imamura, Xiaoyun Liao, Reiko Nishihara, Paul J. Lochhead and Andrew Tan Chan. Their work appears in journals such as Pathology International, Clinical Cancer Research, PLoS ONE, Annals of Surgical Oncology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.